A company still losing money, with high risk.
Facts from SEC filings, not a recommendation.
From MDCX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: -$56.7M.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, net margin 10%+, profitable every year, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
No open-market buys or sells in the last 5 insider filings. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
2,941,176 shares at $0.17 · $501K
1,470,588 shares at $0.17 · $251K
588,235 shares at $0.17 · $100K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page